Bristol-Myers Squibb Company

Last updated September 27, 2026

Organization details

Legal name
Bristol-Myers Squibb Company
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Princeton
Headquarters state / province
New Jersey
Headquarters country
United States
Fiscal year end
December
Ticker symbol
BMY
Primary stock exchange
NYSE

Identifiers

SEC CIK
0000014272
EIN
22-0790350
Wikidata ID
Q266423

Board of directors

Chief executives

Christopher S. Boerner · Chief Executive Officer
Dates unknown
Giovanni Caforio · Board Chair and CEO
Since May 2015
77 CEO score

Strong · grade B

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 50% of the scoring weight is on file.

Dividends 15%
68

dividend grew 5% a year

Revenue growth 20%
81

10.6% a year in revenue

Earnings growth 15%
80

10.1% a year in earnings per share

50% of the scoring weight is on file. Figures cover December 2014 – December 2025.

Director election results

Annual meeting of May 5, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

11 of this board's directors also sit on 17 other boards. 6 are in the same sector.

Network of Bristol-Myers Squibb Company's board connections Accenture plc Accenture plc Agilent Technologies Inc. Agilent Technologies I... Centene Corporation Centene Corporation Colgate-Palmolive Company Colgate-Palmolive Comp... DaVita Inc. DaVita Inc. Faeth Therapeutics Inc. Faeth Therapeutics Inc... GE HealthCare Technologies Inc. GE HealthCare Technolo... Guardant Health Inc. Guardant Health Inc. Iron Mountain Incorporated (Delaware)Common Stock REIT Iron Mountain Incorpor... KLA Corporation KLA Corporation Mondelez International Inc. Mondelez International... Outlook Therapeutics Inc. Outlook Therapeutics I... Stryker Corporation Stryker Corporation Target Corporation Target Corporation The Carlyle Group Inc. The Carlyle Group Inc. The Walt Disney Company The Walt Disney Compan... Christopher S. Boerner Christopher S. Boern... Derica W. Rice Derica W. Rice Giovanni Caforio Giovanni Caforio Julia A. Haller Julia A. Haller Karen H. Vousden Karen H. Vousden Medina Manuel Hidalgo Medina Manuel Hidalg... Michael R. McMullen Michael R. McMullen Paula A. Price Paula A. Price Peter J. Arduini Peter J. Arduini Phyllis R. Yale Phyllis R. Yale Bristol-Myers Squibb Compa...
Shared director Other board Same sector +1 more in the list below

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$2,527,842
5 sales by 4 insiders
Date Insider Transaction Shares Price Value
Nov 5, 2026 Julia A. Haller Director Open-market sale −3,800 $63.31 $240,578
Nov 3, 2026 Lenkowsky Adam Officer (EVP, Chief Commercial Officer) Option exercise +7,522 — —
Nov 3, 2026 Lenkowsky Adam Officer (EVP, Chief Commercial Officer) Shares withheld for tax −3,848 $61.71 $237,460
Nov 1, 2026 Christopher S. Boerner Director, Officer (Chief Executive Officer) Option exercise +2,964 — —
Nov 1, 2026 Meyers Gregory Scott Officer (EVP, Chief Digital & Tech Off.) Option exercise +6,281 — —
Nov 1, 2026 Shanahan Karin Officer (EVP, Chief Supply Chain & Ops) Option exercise +6,281 — —
Nov 1, 2026 Christopher S. Boerner Director, Officer (Chief Executive Officer) Other +406 — —
Nov 1, 2026 Meyers Gregory Scott Officer (EVP, Chief Digital & Tech Off.) Shares withheld for tax −2,665 $62.48 $166,509
Nov 1, 2026 Shanahan Karin Officer (EVP, Chief Supply Chain & Ops) Shares withheld for tax −3,213 $62.48 $200,748
Nov 1, 2026 Christopher S. Boerner Director, Officer (Chief Executive Officer) Shares withheld for tax −1,724 $62.48 $107,716
Oct 2, 2026 Gallman Cari Officer (EVP, General Counsel) Option exercise +4,559 — —
Oct 2, 2026 Gallman Cari Officer (EVP, General Counsel) Shares withheld for tax −2,332 $61.15 $142,602
Sep 9, 2026 Massacesi Cristian Officer (EVP,Chief Med Offr,Head of Dev) Open-market sale −6,249 $64.57 $403,498
Sep 1, 2026 Short Bartie Wendy Officer (EVP, Corporate Affairs) Option exercise +1,236 $66.92 $82,713
Sep 1, 2026 Short Bartie Wendy Officer (EVP, Corporate Affairs) Shares withheld for tax −633 $66.92 $42,360

Organizations in the same sector, closest in location and size first.

Questions about Bristol-Myers Squibb Company

Who is the CEO of Bristol-Myers Squibb Company?

Giovanni Caforio has been Bristol-Myers Squibb Company's Board Chair and CEO since May 2015.

How many directors are on Bristol-Myers Squibb Company's board?

Bristol-Myers Squibb Company's board has 13 directors: Christopher S. Boerner, Deepak Bhatt, Derica W. Rice, Gerald L. Storch, Giovanni Caforio, Julia A. Haller, Karen H. Vousden, Medina Manuel Hidalgo, Michael R. McMullen, Paula A. Price and 3 others.

Are Bristol-Myers Squibb Company insiders buying or selling shares?

Over the last 12 months, Bristol-Myers Squibb Company insiders made no open-market purchases and sold $2.5 million of shares in 5 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="bristol-myers-squibb-company"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.